首页|NLR、IL-19、FeNO诊断COPD频繁加重表型的价值

NLR、IL-19、FeNO诊断COPD频繁加重表型的价值

扫码查看
目的 探究中性粒细胞-淋巴细胞比值(NLR)、白细胞介素-19(IL-19)、呼出气一氧化氮(FeNO)诊断慢性阻塞性肺疾病(COPD)频繁加重表型的价值.方法 回顾性分析2020年7月-2021年7月本院呼吸与危重症医学科收治的180例COPD患者资料,作为研究组,选取同期来院体检的健康者65人为对照组,比较2组NLR、IL-19、FeNO水平.将研究组根据表型分为频繁加重亚组和非频繁加重亚组,比较2亚组的NLR、IL-19、FeNO水平,并采用受试者工作特征曲线(ROC)分析NLR、IL-19、FeNO用于判断慢性阻塞性肺疾病频繁加重表型的价值.结果 研究组 NLR 为(3.35±1.29)、IL-19 为(2 012.29±632.59)pg/mL、FeNO 为(30.40±4.81)ppd,对照组分别为(1.47±0.66)、(1 362.59±538.12)pg/mL、(25.04±2.36)ppd,差异均有统计学意义(t=1 1.221、7.371、8.609,P均<0.001).频繁加重亚组患者的NLR 为(5.32±2.03)、IL-19为(2 276.83±713.44)pg/mL、FeNO为(33.41±9.74)ppd,非频繁加重亚组分别为(1.95±0.74)、(1 823.34±635.58)pg/mL、(28.25±5.39)ppd,差异均有统计学意义(t=15.633、4.483、4.236,P均<0.001).ROC曲线分析显示,NLR、IL-19、FeNO水平用于判断COPD频繁加重表型的AUC分别为0.914、0.671、0.702,敏感性分别为84.00%、53.33%、58.67%,特异性分别为97.14%、75.24%、72.38%,三者联合诊断的AUC为0.937,敏感性为82.67%,特异性为98.10%.结论 COPD频繁加重表型患者NLR、IL-19、FeNO水平升高,对判断COPD频繁急性加重具有一定的临床参考价值.
Value of NLR,IL-19,and FeNO in diagnosing phenotype of frequent ex-acerbation of chronic obstructive pulmonary disease
Objective To explore the value of neutrophil-lymphocyte ratio(NLR),interleukin-19(IL-19),and frac-tion exhaled nitric oxide(FeNO)in diagnosing the phenotype of frequent exacerbation of chronic obstructive pulmonary disease(COPD).Methods A retrospective analysis was performed for the data of 180 COPD patients admitted to the De-partment of Respiratory and Critical Care Medicine from July 2020 to July 2021 as a study group,and 65 healthy patients who came to the hospital for physical examination during the same period were selected as a control group,and the levels of NLR,IL-19,and FeNO were compared between the two groups.The study group was divided into a frequent exacerbation subgroup and a non-frequent exacerbation subgroup according to phenotype,and the levels of NLR,IL-19,and FeNO in the two subgroups were compared,and the receiver operating characteristic(ROC)curve was used to analyze the value of NLR,IL-19,and FeNO in judging the phenotype of frequent exacerbation of COPD.Results The NLR of the study group was(3.35±1.29),IL-19 was(2 012.29±632.59)pg/mL,and FeNO was(30.40±4.81)ppd,while those of the control group were(1.47±0.66),(1 362.59±538.12)pg/mL,and(25.04±2.36)ppd,respectively,with statistically significant differences(t=1 1.221,7.371,8.609,all P<0.001).The NLR of the frequent exacerbation subgroup was(5.32±2.03),IL-19 was(2 276.83±713.44)μg/mL,and FeNO was(33.41±9.74)ppd,while those of the infrequent exacerbation subgroup were(1.95±0.74),(1 823.34±635.58)pg/mL,and(28.25±5.39)ppd,respectively,with statistically significant differences(t=15.633,4.483,4.236,all P<0.001).ROC curve analysis showed that the area under the curves(AUCs)of NLR,IL-19 and FeNO levels for judging the phenotype of frequent exacerbations of COPD were 0.914,0.671,and 0.702,respectively,the sensitivity was 84.00%,53.33%and 58.67%,and the specificity was 97.14%,75.24%,and 72.38%,respectively,and the AUC of the combined diagnosis of the three was 0.937,the sensi-tivity was 82.67%,and the specificity was 98.10%.Conclu-sion The levels of NLR,IL-19,and FeNO are increased in patients with frequent exacerbations of COPD,which has a cer-tain clinical reference value forjudging frequent acute exacerbations of COPD.

Neutrophil-lymphocyte ratio(NLR)Interleukin-19(IL-19)Fraction exhaled nitric oxide(FENO)Chronic obstructive pulmonary disease

李伟国

展开 >

伊川县人民医院呼吸与危重症医学科,河南伊川 471300

中性粒细胞-淋巴细胞比值 白细胞介素-19 呼出气一氧化氮 慢性阻塞性肺疾病

2024

中国校医
江苏省预防医学会 中华预防医学会

中国校医

影响因子:0.378
ISSN:1001-7062
年,卷(期):2024.38(3)